Literature DB >> 22125159

Hepatitis C virus--T-cell responses and viral escape mutations.

Danijela Petrovic1, Eugene Dempsey, Derek G Doherty, Dermot Kelleher, Aideen Long.   

Abstract

Hepatitis C virus (HCV) is a small, enveloped RNA virus and the number of HCV-infected individuals worldwide is estimated to be approximately 170 million. Most HCV infections persist, with up to 80% of all cases leading to chronic hepatitis associated with liver fibrosis, cirrhosis, and hepatocellular carcinoma. HCV-host interactions have a crucial role in viral survival, persistence, pathogenicity of infection, and disease progression. Maintenance of a vigorous, sustained cellular immune response recognizing multiple epitopes is essential for viral clearance. To escape immune surveillance, HCV alters its epitopes so that they are no-longer recognized by T cells and neutralizing antibodies, in addition to interfering with host cell cellular components and signaling pathways. The generation of escape variants is one of the most potent immune evasion strategies utilized by HCV. A large body of evidence suggests that single or multiple mutations within HLA-restricted epitopes contribute to viral immune escape and establishment of viral persistence. Further elucidation of the molecular mechanisms underlying immune escape will aid in the design of novel vaccines and therapeutics for the disease.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22125159     DOI: 10.1002/eji.201141593

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

1.  Statistical linkage analysis of substitutions in patient-derived sequences of genotype 1a hepatitis C virus nonstructural protein 3 exposes targets for immunogen design.

Authors:  Ahmed A Quadeer; Raymond H Y Louie; Karthik Shekhar; Arup K Chakraborty; I-Ming Hsing; Matthew R McKay
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

2.  Identification and retrospective validation of T-cell epitopes in the hepatitis C virus genotype 4 proteome: an accelerated approach toward epitope-driven vaccine development.

Authors:  Karim M Abdel-Hady; Andres H Gutierrez; Frances Terry; Joe Desrosiers; Anne S De Groot; Hassan M E Azzazy
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 3.  The role of chemokines in acute and chronic hepatitis C infection.

Authors:  Stephen Fahey; Eugene Dempsey; Aideen Long
Journal:  Cell Mol Immunol       Date:  2013-08-19       Impact factor: 11.530

4.  Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection.

Authors:  Ivan Osokine; Laura M Snell; Cameron R Cunningham; Douglas H Yamada; Elizabeth B Wilson; Heidi J Elsaesser; Juan Carlos de la Torre; David Brooks
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-05       Impact factor: 11.205

5.  Hepatitis C virus suppresses C9 complement synthesis and impairs membrane attack complex function.

Authors:  Hangeun Kim; Keith Meyer; Adrian M Di Bisceglie; Ranjit Ray
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

6.  Cell-cell contact-mediated hepatitis C virus (HCV) transfer, productive infection, and replication and their requirement for HCV receptors.

Authors:  Ziqing Liu; Johnny J He
Journal:  J Virol       Date:  2013-05-29       Impact factor: 5.103

Review 7.  Hepatitis C Virus Manipulates Humans as its Favorite Host for a Long-Term Relationship.

Authors:  Ratna B Ray; Ranjit Ray
Journal:  Hepatology       Date:  2019-02       Impact factor: 17.425

8.  Inhibition of c3 convertase activity by hepatitis C virus as an additional lesion in the regulation of complement components.

Authors:  Hangeun Kim; Keith Meyer; Adrian M Di Bisceglie; Ranjit Ray
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

9.  Smarter vaccine design will circumvent regulatory T cell-mediated evasion in chronic HIV and HCV infection.

Authors:  Leonard Moise; Frances Terry; Andres H Gutierrez; Ryan Tassone; Phyllis Losikoff; Stephen H Gregory; Chris Bailey-Kellogg; William D Martin; Anne S De Groot
Journal:  Front Microbiol       Date:  2014-10-06       Impact factor: 5.640

10.  Prediction of T-cell epitopes of hepatitis C virus genotype 5a.

Authors:  Maemu P Gededzha; M Jeffrey Mphahlele; Selokela G Selabe
Journal:  Virol J       Date:  2014-11-08       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.